Patient and caregiver’s satisfaction with multidisciplinary vs. serial lung cancer care in a community setting.

Authors

null

Huibo Shao

Baptist Cancer Center, Memphis, TN

Huibo Shao, Nicholas Faris, Meghan Brooke Taylor, Carrie Fehnel, Anita Patel, Samantha Weller, Courtney Berryman, Olawale Akinbobola, Alicia Pacheco, Laura McHugh, Margaret Debon, Matthew Smeltzer, Meredith Ray, Todd Robbins, Kenneth Daniel Ward, Raymond U. Osarogiagbon

Organizations

Baptist Cancer Center, Memphis, TN, Baptist Cancer Center, Multidisciplinary Thoracic Oncology Department, Memphis, TN, Baptist Memorial Health Care Corporation, Memphis, TN, Baptist Cancer Center, Multidisciplinary Thoracic Oncology Program, Memphis, TN, Baptist Clinical Research Institute, Memphis, TN, University of Memphis, School of Public Health, Memphis, TN, Multidisciplinary Thoracic Oncology Department, Baptist Cancer Center, Memphis, TN

Research Funding

Other
Patient Centered Outcomes Research Institute

Background: Few existing studies examined lung cancer patients and caregivers’ satisfaction with the team-based multidisciplinary care (MD) in comparison to the usual serial care (SC). We hypothesized that MD, by providing early and concurrent input from key specialists collaborating as a team with patients and caregivers to develop a consensus care plan, can improve patients and caregivers’ satisfaction with care, compared to SC, in which multiple specialists independently screen, diagnose, and treat patients through a fragmented sequence of referrals. Methods: Data on newly diagnosed lung cancer patients, enrolled in a prospective matched cohort comparative effectiveness trial of MD or SC between Oct. 9th, 2014 and July 5th, 2017 in a Mid-South community hospital system, were collected at baseline, 3- and 6-month periods to assess patient and caregiver’s satisfaction with these two care-delivery models. Measures of satisfaction were adapted from the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey. Multivariate mixed linear models were used to examine the cross-group differences, the time-related variances, and how the interaction between groups and time-periods influenced patients’ and caregivers’ satisfaction. Results: Compared with SC (N = 297), patients in MD (N = 159) were older (66 vs. 69 years), more in an early cancer stage (33% vs. 41% in stage I or II), and lower in performance score (35% vs. 45% asymptomatic). Demographic and social-economic characteristics of caregivers in MD (N = 97) and SC (N = 122) were not significantly different. Patients and caregivers in MD were more likely than those in SC to perceive their care to be better than that received by other patients (p =.003 and p <.001 respectively). Greater satisfaction with their treatment plan at 6-month was observed among the MD patients (p =.004). Also, MD patients reported better overall satisfaction with team members (p =.038). Consistent with the findings among the patients in MD, caregivers in MD were more satisfied with the quality of care (p <.001) and with care received from team members (p <.001) than that reported by caregivers in SC. Conclusions: Coordinated MD care improved patients and caregivers’ satisfaction with lung cancer care in a community healthcare system. Further research will compare the quality of life and financial burden on patients in the MD and SC treatment models to provide more evidence for stakeholders to refine cancer care models.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2021 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Patient Experience; Quality, Safety, and Implementation Science; Technology and Innovation in Quality of Care

Track

Technology and Innovation in Quality of Care,Patient Experience,Quality, Safety, and Implementation Science,Cost, Value, and Policy,Health Care Access, Equity, and Disparities

Sub Track

Provider Impact on Quality From the Patient Perspective

Citation

J Clin Oncol 39, 2021 (suppl 28; abstr 200)

DOI

10.1200/JCO.2020.39.28_suppl.200

Abstract #

200

Poster Bd #

Online Only

Abstract Disclosures

Similar Abstracts

Abstract

2019 ASCO Annual Meeting

Prospective comparative effectiveness trial of multidisciplinary lung cancer (LC) care.

First Author: Raymond U. Osarogiagbon

Abstract

2023 ASCO Annual Meeting

Real-world program-based lung cancer care.

First Author: Wei Liao

First Author: Nicole Henderson